Androgen [EPC]

Androgen [EPC] was reported 27346 times

These side effects are most commonly reported by patients taking drugs of the Androgen [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 2193
1 OFF LABEL USE 1851
2 FATIGUE 1541
3 PAIN 1407
4 HEADACHE 1274
5 NAUSEA 1155
6 MYOCARDIAL INFARCTION 1055
7 ANXIETY 1020
8 DEEP VEIN THROMBOSIS 902
9 PULMONARY EMBOLISM 876
10 CEREBROVASCULAR ACCIDENT 865
11 ASTHENIA 860
12 DIARRHOEA 774
13 DYSPNOEA 759
14 DIZZINESS 754
15 ARTHRALGIA 727
16 INSOMNIA 626
17 DEPRESSION 586
18 DEATH 580
19 MALAISE 573
20 WEIGHT DECREASED 557
21 NO ADVERSE EVENT 539
22 VOMITING 518
23 FALL 513
24 PRODUCT DOSE OMISSION ISSUE 504
25 FEELING ABNORMAL 495
26 HYPERTENSION 494
27 RASH 490
28 PNEUMONIA 485
29 BACK PAIN 484
30 PAIN IN EXTREMITY 483
31 PRODUCT USE IN UNAPPROVED INDICATION 481
32 BLOOD TESTOSTERONE DECREASED 458
33 HYPERSENSITIVITY 457
34 PRURITUS 453
35 ACUTE MYOCARDIAL INFARCTION 448
36 WEIGHT INCREASED 442
37 CONDITION AGGRAVATED 440
38 THROMBOSIS 440
39 CONSTIPATION 433
40 CHEST PAIN 429
41 DRUG ABUSE 425
42 PYREXIA 411
43 COUGH 388
44 INJECTION SITE PAIN 385
45 ABDOMINAL PAIN 384
46 BLOOD PRESSURE INCREASED 363
47 CARDIAC FAILURE CONGESTIVE 355
48 EMOTIONAL DISTRESS 351
49 DRUG INTOLERANCE 347
50 MYALGIA 343
51 ATRIAL FIBRILLATION 342
52 DYSPHONIA 337
53 INCORRECT DOSE ADMINISTERED 337
54 CORONARY ARTERY DISEASE 331
55 PRODUCT USE ISSUE 331
56 ACUTE KIDNEY INJURY 329
57 MUSCLE SPASMS 329
58 SWELLING FACE 321
59 DRUG INTERACTION 317
60 PRODUCT QUALITY ISSUE 316
61 SOMNOLENCE 316
62 ANGIOEDEMA 311
63 GAIT DISTURBANCE 310
64 ANAEMIA 309
65 HYPERHIDROSIS 307
66 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 306
67 POLYCYTHAEMIA 302
68 DECREASED APPETITE 300
69 SWOLLEN TONGUE 288
70 ECONOMIC PROBLEM 282
71 RENAL FAILURE 282
72 PERIPHERAL SWELLING 271
73 PLATELET COUNT DECREASED 269
74 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 264
75 OEDEMA PERIPHERAL 262
76 TREMOR 259
77 ANHEDONIA 258
78 CARDIOVASCULAR DISORDER 255
79 PARAESTHESIA 252
80 MIGRAINE 248
81 HAEMOGLOBIN DECREASED 247
82 COVID-19 244
83 ABDOMINAL PAIN UPPER 242
84 BLOOD TESTOSTERONE INCREASED 241
85 HEREDITARY ANGIOEDEMA 241
86 INTENTIONAL PRODUCT MISUSE 240
87 CHRONIC KIDNEY DISEASE 239
88 HYPOAESTHESIA 239
89 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 236
90 CONTUSION 228
91 ERYTHEMA 224
92 HYPOTENSION 221
93 MEMORY IMPAIRMENT 219
94 ALOPECIA 217
95 ABDOMINAL DISCOMFORT 213
96 CONFUSIONAL STATE 213
97 SUICIDAL IDEATION 213
98 SINUSITIS 209
99 FLUSHING 208
100 THROMBOCYTOPENIA 204
101 INJURY 203
102 DEHYDRATION 202
103 JOINT SWELLING 202
104 QUALITY OF LIFE DECREASED 202
105 BLOOD GLUCOSE INCREASED 200
106 INFLUENZA 197
107 CARDIAC DISORDER 196
108 PRESCRIBED OVERDOSE 195
109 STRESS 195
110 HEPATIC ENZYME INCREASED 194
111 ERECTILE DYSFUNCTION 193
112 LOSS OF CONSCIOUSNESS 193
113 INTENTIONAL PRODUCT USE ISSUE 190
114 UNEVALUABLE EVENT 190
115 GASTROOESOPHAGEAL REFLUX DISEASE 188
116 NASOPHARYNGITIS 188
117 INFECTION 187
118 ABDOMINAL DISTENSION 185
119 CARDIAC ARREST 185
120 SEPSIS 185
121 RENAL IMPAIRMENT 184
122 DRUG DOSE OMISSION 183
123 NEUROPATHY PERIPHERAL 183
124 PALPITATIONS 182
125 VISION BLURRED 182
126 URTICARIA 181
127 BALANCE DISORDER 180
128 HEART RATE INCREASED 178
129 URINARY TRACT INFECTION 178
130 PRODUCT STORAGE ERROR 177
131 SLEEP APNOEA SYNDROME 176
132 MUSCULAR WEAKNESS 175
133 DRUG HYPERSENSITIVITY 174
134 OSTEONECROSIS 174
135 SYNCOPE 173
136 PRODUCT SUBSTITUTION ISSUE 172
137 HOT FLUSH 171
138 CHEST DISCOMFORT 169
139 AMNESIA 168
140 DEVICE DELIVERY SYSTEM ISSUE 168
141 SWELLING 165
142 CHILLS 162
143 THERAPEUTIC PRODUCT EFFECT DECREASED 162
144 IRRITABILITY 160
145 SLEEP DISORDER 158
146 VISUAL IMPAIRMENT 158
147 TRANSIENT ISCHAEMIC ATTACK 157
148 PRODUCT DELIVERY MECHANISM ISSUE 155
149 DYSPEPSIA 154
150 ILLNESS 153
151 RHABDOMYOLYSIS 149
152 BLOOD CREATININE INCREASED 148
153 CARDIOMYOPATHY 147
154 PRODUCT DEPOSIT 147
155 ACCIDENTAL EXPOSURE TO PRODUCT 145
156 INFUSION RELATED REACTION 144
157 DIABETES MELLITUS 143
158 SEIZURE 142
159 BRONCHITIS 140
160 DRUG DOSE OMISSION BY DEVICE 140
161 TACHYCARDIA 140
162 THERAPEUTIC RESPONSE DECREASED 140
163 IMPAIRED WORK ABILITY 139
164 PRODUCT ODOUR ABNORMAL 139
165 NEUTROPENIA 138
166 DISTURBANCE IN ATTENTION 137
167 INFARCTION 137
168 CELLULITIS 136
169 AGITATION 134
170 EPISTAXIS 134
171 FEAR 134
172 GENERAL PHYSICAL HEALTH DETERIORATION 134
173 EMOTIONAL DISORDER 132
174 NEPHROLITHIASIS 131
175 POLLAKIURIA 131
176 ISCHAEMIA 130
177 OVERDOSE 130
178 OSTEOPOROSIS 129
179 DEPRESSED MOOD 127
180 ARTHRITIS 126
181 BREAST CANCER 125
182 BURNING SENSATION 125
183 CARDIAC FAILURE 125
184 HAEMORRHAGE 125
185 NECK PAIN 125
186 ACNE 124
187 DRY MOUTH 124
188 WHITE BLOOD CELL COUNT DECREASED 124
189 DEVICE MALFUNCTION 123
190 PANCREATITIS 123
191 PSORIASIS 122
192 ASTHMA 121
193 IDIOPATHIC INTRACRANIAL HYPERTENSION 121
194 DRY SKIN 120
195 LETHARGY 119
196 THERAPEUTIC RESPONSE UNEXPECTED 119
197 BONE PAIN 118
198 OSTEOARTHRITIS 118
199 RESPIRATORY FAILURE 118
200 DYSPHAGIA 117
201 INFLUENZA LIKE ILLNESS 117
202 SURGERY 117
203 PROSTATE CANCER 116
204 AGGRESSION 115
205 HYPONATRAEMIA 113
206 LIBIDO DECREASED 113
207 GASTROINTESTINAL HAEMORRHAGE 111
208 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 111
209 MUSCULOSKELETAL STIFFNESS 111
210 HAEMOLYSIS 110
211 INJECTION SITE SWELLING 110
212 ANGER 108
213 DYSGEUSIA 108
214 NASAL CONGESTION 108
215 TINNITUS 108
216 TREATMENT NONCOMPLIANCE 108
217 OROPHARYNGEAL PAIN 106
218 ARTHROPATHY 105
219 DRUG EFFECT DECREASED 105
220 OSTEOPENIA 105
221 RHINORRHOEA 104
222 HOSPITALISATION 103
223 PRODUCT PHYSICAL CONSISTENCY ISSUE 103
224 UPPER RESPIRATORY TRACT INFECTION 103
225 ROAD TRAFFIC ACCIDENT 101
226 INJECTION SITE ERYTHEMA 100
227 MOBILITY DECREASED 100
228 NIGHT SWEATS 100
229 PANIC ATTACK 100
230 DEVICE ISSUE 99
231 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 99
232 DISCOMFORT 98
233 DRUG WITHDRAWAL SYNDROME 98
234 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 97
235 ALANINE AMINOTRANSFERASE INCREASED 96
236 BLOOD CHOLESTEROL INCREASED 96
237 INJECTION SITE HAEMORRHAGE 96
238 ADVERSE DRUG REACTION 95
239 GASTROINTESTINAL DISORDER 95
240 PRODUCT ADHESION ISSUE 95
241 BONE DENSITY DECREASED 94
242 UNDERDOSE 94
243 PRODUCT PHYSICAL ISSUE 92
244 DISEASE PROGRESSION 90
245 INCORRECT DOSE ADMINISTERED BY DEVICE 90
246 LYMPHADENITIS 90
247 EYE PAIN 89
248 FEELING HOT 89
249 MOOD SWINGS 89
250 COGNITIVE DISORDER 88
251 MUSCULOSKELETAL PAIN 88
252 RASH PRURITIC 88
253 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 87
254 HEAD INJURY 87
255 LIMB INJURY 87
256 OEDEMA 87
257 CHOLELITHIASIS 86
258 FLUID RETENTION 86
259 INJECTION SITE BRUISING 85
260 HALLUCINATION 84
261 MENTAL DISORDER 84
262 APPLICATION SITE PAIN 83
263 LIQUID PRODUCT PHYSICAL ISSUE 83
264 PLEURAL EFFUSION 83
265 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 83
266 PRODUCTIVE COUGH 83
267 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 82
268 FLATULENCE 82
269 HAEMATOCHEZIA 82
270 NERVOUSNESS 82
271 PRODUCT ADMINISTRATION ERROR 82
272 BREAST CANCER FEMALE 81
273 TOXICITY TO VARIOUS AGENTS 81
274 LUNG DISORDER 80
275 POOR QUALITY PRODUCT ADMINISTERED 80
276 PRODUCT DOSE OMISSION 80
277 DRUG-INDUCED LIVER INJURY 79
278 PRODUCT PACKAGING QUANTITY ISSUE 79
279 ARRHYTHMIA 78
280 BLOOD PRESSURE DECREASED 78
281 DISORIENTATION 78
282 BLISTER 77
283 CATARACT 77
284 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 77
285 HERPES ZOSTER 77
286 RENAL DISORDER 77
287 WHITE BLOOD CELL COUNT INCREASED 77
288 THERAPY NON-RESPONDER 76
289 INFLAMMATION 75
290 SKIN EXFOLIATION 75
291 WITHDRAWAL SYNDROME 75
292 APPLICATION SITE ERYTHEMA 74
293 PULMONARY OEDEMA 74
294 VERTIGO 74
295 ABNORMAL BEHAVIOUR 73
296 ADVERSE EVENT 73
297 GYNAECOMASTIA 73
298 LEFT VENTRICULAR HYPERTROPHY 72
299 MENTAL STATUS CHANGES 72
300 RENAL FAILURE ACUTE 72
301 THROAT IRRITATION 72
302 ANGINA PECTORIS 71
303 DISEASE RECURRENCE 71
304 INJECTION SITE MASS 71
305 RED BLOOD CELL COUNT DECREASED 70
306 WHEEZING 70
307 APPLICATION SITE PRURITUS 69
308 APPLICATION SITE RASH 69
309 HAEMOGLOBIN INCREASED 69
310 HEART RATE DECREASED 69
311 HYPERSOMNIA 69
312 STAPHYLOCOCCAL INFECTION 69
313 ASPARTATE AMINOTRANSFERASE INCREASED 68
314 CHROMATURIA 68
315 DYSURIA 68
316 EYE IRRITATION 68
317 OXYGEN SATURATION DECREASED 67
318 PROSTATIC SPECIFIC ANTIGEN INCREASED 67
319 SPLENOMEGALY 67
320 HAIR GROWTH ABNORMAL 66
321 HYPERKALAEMIA 66
322 IMPAIRED HEALING 66
323 IMPLANT SITE PAIN 66
324 MOOD ALTERED 66
325 NEURALGIA 66
326 TREATMENT FAILURE 66
327 CEREBRAL INFARCTION 65
328 DYSARTHRIA 65
329 HAEMATOCRIT INCREASED 65
330 ILL-DEFINED DISORDER 65
331 INTERVERTEBRAL DISC PROTRUSION 65
332 ISCHAEMIC STROKE 65
333 LOSS OF LIBIDO 65
334 MEDICATION ERROR 65
335 THERAPY CESSATION 65
336 BLOOD TRIGLYCERIDES INCREASED 64
337 HEART RATE IRREGULAR 64
338 HYPOTHYROIDISM 64
339 SPEECH DISORDER 64
340 TYPE 2 DIABETES MELLITUS 64
341 CORONARY ARTERY OCCLUSION 63
342 DRUG ADMINISTRATION ERROR 63
343 GASTRITIS 63
344 HYPOGLYCAEMIA 63
345 HYPOKALAEMIA 63
346 JOINT INJURY 63
347 LACRIMATION INCREASED 63
348 COMPLETED SUICIDE 62
349 DYSPNOEA EXERTIONAL 62
350 EYE SWELLING 62
351 LYMPHADENOPATHY 62
352 PALLOR 62
353 POOR QUALITY SLEEP 62
354 THERAPY INTERRUPTED 62
355 CROHN^S DISEASE 61
356 END STAGE RENAL DISEASE 61
357 MENTAL IMPAIRMENT 61
358 PRE-EXISTING CONDITION IMPROVED 61
359 RESTLESSNESS 61
360 ANAPHYLACTIC REACTION 60
361 DRY EYE 60
362 HYPERGLYCAEMIA 60
363 PAIN IN JAW 60
364 PSORIATIC ARTHROPATHY 60
365 LABORATORY TEST ABNORMAL 59
366 NEEDLE ISSUE 59
367 GOUT 58
368 HYPERLIPIDAEMIA 58
369 OCULAR HYPERAEMIA 58
370 RHEUMATOID ARTHRITIS 58
371 SKIN DISCOLOURATION 58
372 BRADYCARDIA 57
373 BRAIN FOG 57
374 DEVICE BREAKAGE 57
375 EXPULSION OF MEDICATION 57
376 INJECTION SITE PRURITUS 57
377 PRODUCT PRESCRIBING ERROR 57
378 BLOOD GLUCOSE DECREASED 56
379 CARDIOMEGALY 56
380 CRYING 56
381 DEVICE DISLOCATION 56
382 RENAL INFARCT 56
383 SKIN LESION 56
384 SUICIDE ATTEMPT 56
385 DRUG ADMINISTERED AT INAPPROPRIATE SITE 55
386 DRUG DEPENDENCE 55
387 EXPIRED PRODUCT ADMINISTERED 55
388 HAEMATURIA 55
389 MALIGNANT NEOPLASM PROGRESSION 55
390 DEVICE LEAKAGE 54
391 INJECTION SITE REACTION 54
392 INTERNATIONAL NORMALISED RATIO INCREASED 54
393 INTRACRANIAL PRESSURE INCREASED 54
394 LIVER FUNCTION TEST ABNORMAL 54
395 NIGHTMARE 54
396 PAPILLOEDEMA 54
397 PSYCHOTIC DISORDER 54
398 ABNORMAL DREAMS 53
399 APPLICATION SITE IRRITATION 53
400 BLOOD TESTOSTERONE ABNORMAL 53
401 CEREBRAL HAEMORRHAGE 53
402 HAEMATOMA 53
403 NEOPLASM PROGRESSION 53
404 NOCTURIA 53
405 PHYSICAL DISABILITY 53
406 BLINDNESS 52
407 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 52
408 HEPATOCELLULAR CARCINOMA 52
409 LACERATION 52
410 LEUKOCYTOSIS 52
411 LOCALISED INFECTION 52
412 MIDDLE INSOMNIA 52
413 PRECOCIOUS PUBERTY 52
414 PRODUCT CONTAINER ISSUE 52
415 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 52
416 SINUS DISORDER 52
417 STOMATITIS 52
418 ACUTE RESPIRATORY FAILURE 51
419 BONE DISORDER 51
420 SELF-MEDICATION 51
421 ACUTE CORONARY SYNDROME 50
422 CLEAR CELL RENAL CELL CARCINOMA 50
423 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 50
424 MYELODYSPLASTIC SYNDROME 50
425 NEPHROPATHY 50
426 NERVOUS SYSTEM DISORDER 50
427 PANCYTOPENIA 50
428 PORTAL VEIN THROMBOSIS 50
429 PRESYNCOPE 50
430 SKIN DISORDER 50
431 SKIN LACERATION 50
432 URINARY RETENTION 50
433 VAGINAL HAEMORRHAGE 50
434 ARTERIOSCLEROSIS 49
435 ECZEMA 49
436 HEPATIC STEATOSIS 49
437 NERVE INJURY 49
438 OBESITY 49
439 RASH MACULAR 49
440 RIB FRACTURE 49
441 VIRAL INFECTION 49
442 CARDIOGENIC SHOCK 48
443 DERMATITIS ATOPIC 48
444 HYPOXIA 48
445 JAUNDICE 48
446 LYMPHOPROLIFERATIVE DISORDER 48
447 MITRAL VALVE INCOMPETENCE 48
448 NEOPLASM MALIGNANT 48
449 PLATELET COUNT INCREASED 48
450 RASH ERYTHEMATOUS 48
451 WOUND 48
452 ARTERIOSCLEROSIS CORONARY ARTERY 47
453 BASAL CELL CARCINOMA 47
454 BLOOD CREATINE PHOSPHOKINASE INCREASED 47
455 CENTRAL SEROUS CHORIORETINOPATHY 47
456 CONVULSION 47
457 DIVERTICULITIS 47
458 EATING DISORDER 47
459 MALIGNANT MELANOMA 47
460 MESENTERIC VEIN THROMBOSIS 47
461 MUSCLE TWITCHING 47
462 PROTEINURIA 47
463 THINKING ABNORMAL 47
464 EAR INFECTION 46
465 FIBROMYALGIA 46
466 INTENTIONAL DOSE OMISSION 46
467 LIMB DISCOMFORT 46
468 PRODUCT AVAILABILITY ISSUE 46
469 SKIN IRRITATION 46
470 URINARY INCONTINENCE 46
471 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 46
472 AGEUSIA 45
473 ATRIAL FLUTTER 45
474 CARDIO-RESPIRATORY ARREST 45
475 FOOT FRACTURE 45
476 JOINT STIFFNESS 45
477 MULTIPLE ORGAN DYSFUNCTION SYNDROME 45
478 MUSCULOSKELETAL DISCOMFORT 45
479 MYOCARDITIS 45
480 PARANOIA 45
481 RESTLESS LEGS SYNDROME 45
482 SCAR 45
483 AORTIC ANEURYSM 44
484 COLITIS ULCERATIVE 44
485 DIPLOPIA 44
486 EPILEPSY 44
487 FEELING JITTERY 44
488 LIVER DISORDER 44
489 MULTIPLE USE OF SINGLE-USE PRODUCT 44
490 PRODUCT ADMINISTRATION INTERRUPTED 44
491 RED BLOOD CELL COUNT INCREASED 44
492 RESPIRATORY DISORDER 44
493 SEASONAL ALLERGY 44
494 THROAT TIGHTNESS 44
495 BLOOD BILIRUBIN INCREASED 43
496 GLOMERULAR FILTRATION RATE DECREASED 43
497 HAEMOPTYSIS 43
498 HEPATIC ADENOMA 43
499 IMPLANT SITE INFECTION 43
500 IRRITABLE BOWEL SYNDROME 43
501 METABOLIC ACIDOSIS 43
502 PRODUCT DISPENSING ERROR 43
503 RECALLED PRODUCT ADMINISTERED 43
504 ROTATOR CUFF SYNDROME 43
505 SECONDARY HYPOGONADISM 43
506 TESTICULAR ATROPHY 43
507 VENTRICULAR FIBRILLATION 43
508 BENIGN PROSTATIC HYPERPLASIA 42
509 BLOOD POTASSIUM DECREASED 42
510 BLOOD PRESSURE SYSTOLIC INCREASED 42
511 GINGIVAL BLEEDING 42
512 HAEMATOCRIT DECREASED 42
513 HYPERCALCAEMIA 42
514 INSULIN-LIKE GROWTH FACTOR INCREASED 42
515 INTESTINAL OBSTRUCTION 42
516 ISCHAEMIC CARDIOMYOPATHY 42
517 MANIA 42
518 PULMONARY HYPERTENSION 42
519 RENAL INJURY 42
520 SEXUAL DYSFUNCTION 42
521 SKIN ULCER 42
522 TOOTHACHE 42
523 EMBOLISM 41
524 GLYCOSYLATED HAEMOGLOBIN INCREASED 41
525 HEPATOMEGALY 41
526 MYELOFIBROSIS 41
527 PROCEDURAL PAIN 41
528 TENDONITIS 41
529 THROMBOCYTOSIS 41
530 APHASIA 40
531 BODY HEIGHT DECREASED 40
532 CYSTITIS 40
533 DRUG EFFECT LESS THAN EXPECTED 40
534 HORMONE LEVEL ABNORMAL 40
535 HYPOGONADISM 40
536 INVASIVE DUCTAL BREAST CARCINOMA 40
537 LEFT VENTRICULAR DYSFUNCTION 40
538 MUSCLE ATROPHY 40
539 MUSCULOSKELETAL CHEST PAIN 40
540 OBSTRUCTIVE SLEEP APNOEA SYNDROME 40
541 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 39
542 ATELECTASIS 39
543 BLOOD PRESSURE FLUCTUATION 39
544 DYSSTASIA 39
545 FEELING COLD 39
546 HAEMORRHOIDS 39
547 HEPATIC FAILURE 39
548 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 39
549 PRODUCT USE COMPLAINT 39
550 SPINAL OSTEOARTHRITIS 39
551 STEVENS-JOHNSON SYNDROME 39
552 BLOOD PRESSURE ABNORMAL 38
553 BRAIN INJURY 38
554 CARDIAC VENTRICULAR THROMBOSIS 38
555 DECREASED ACTIVITY 38
556 DEVICE DEFECTIVE 38
557 DRUG EFFECT INCOMPLETE 38
558 FUNGAL INFECTION 38
559 INTENTIONAL OVERDOSE 38
560 UPPER LIMB FRACTURE 38
561 ACCIDENTAL EXPOSURE 37
562 BLOOD LACTATE DEHYDROGENASE INCREASED 37
563 BLOOD URINE PRESENT 37
564 BONE MARROW FAILURE 37
565 CARPAL TUNNEL SYNDROME 37
566 DISABILITY 37
567 FEBRILE NEUTROPENIA 37
568 HEPATIC FUNCTION ABNORMAL 37
569 IMPAIRED GASTRIC EMPTYING 37
570 MYOCARDIAL ISCHAEMIA 37
571 PANCREATITIS ACUTE 37
572 POST PROCEDURAL COMPLICATION 37
573 PULMONARY MASS 37
574 RECTAL HAEMORRHAGE 37
575 SKIN BURNING SENSATION 37
576 SKIN INFECTION 37
577 TUBULOINTERSTITIAL NEPHRITIS 37
578 ANKLE FRACTURE 36
579 BACK DISORDER 36
580 BRAIN OEDEMA 36
581 COMA 36
582 ENCEPHALOPATHY 36
583 FLANK PAIN 36
584 HERNIA 36
585 INSURANCE ISSUE 36
586 PRODUCT DOSE OMISSION IN ERROR 36
587 PRODUCT PRESCRIBING ISSUE 36
588 SEPTIC SHOCK 36
589 SINUS TACHYCARDIA 36
590 TEMPERATURE INTOLERANCE 36
591 TENDON RUPTURE 36
592 ABSCESS 35
593 BLOOD ALKALINE PHOSPHATASE INCREASED 35
594 BLOOD UREA INCREASED 35
595 INTERVERTEBRAL DISC DEGENERATION 35
596 NEUTROPHIL COUNT DECREASED 35
597 RECALLED PRODUCT 35
598 RENAL TUBULAR NECROSIS 35
599 RESPIRATORY TRACT INFECTION 35
600 WRONG TECHNIQUE IN DRUG USAGE PROCESS 35
601 ADRENAL INSUFFICIENCY 34
602 APATHY 34
603 BLOOD GLUCOSE ABNORMAL 34
604 COLD SWEAT 34
605 CYST 34
606 DEAFNESS 34
607 DYSKINESIA 34
608 ELECTROCARDIOGRAM QT PROLONGED 34
609 ERUCTATION 34
610 HEAD DISCOMFORT 34
611 HEPATOTOXICITY 34
612 MULTIPLE SCLEROSIS RELAPSE 34
613 ORAL PAIN 34
614 PHOTOSENSITIVITY REACTION 34
615 THERAPEUTIC RESPONSE SHORTENED 34
616 THROMBOPHLEBITIS SUPERFICIAL 34
617 VISUAL ACUITY REDUCED 34
618 VISUAL FIELD DEFECT 34
619 ASCITES 33
620 BLOOD COUNT ABNORMAL 33
621 CONGESTIVE CARDIOMYOPATHY 33
622 DERMATITIS 33
623 EXPOSURE VIA SKIN CONTACT 33
624 EYE PRURITUS 33
625 FREQUENT BOWEL MOVEMENTS 33
626 INCREASED APPETITE 33
627 PETECHIAE 33
628 PLATELET COUNT ABNORMAL 33
629 PROSTATOMEGALY 33
630 RENAL CELL CARCINOMA 33
631 TOOTH LOSS 33
632 ACTIVITIES OF DAILY LIVING IMPAIRED 32
633 AFFECTIVE DISORDER 32
634 CLOSTRIDIUM DIFFICILE INFECTION 32
635 ECCHYMOSIS 32
636 FEMUR FRACTURE 32
637 HYPOACUSIS 32
638 PITUITARY TUMOUR BENIGN 32
639 PSYCHIATRIC SYMPTOM 32
640 SKIN CANCER 32
641 THYROID DISORDER 32
642 TOOTH INFECTION 32
643 BACK INJURY 31
644 CHOLECYSTECTOMY 31
645 COLITIS 31
646 CUSHINGOID 31
647 DEVICE RELATED INFECTION 31
648 HALLUCINATION, VISUAL 31
649 HEPATITIS 31
650 HIP ARTHROPLASTY 31
651 HYPERTHYROIDISM 31
652 KNEE ARTHROPLASTY 31
653 MOVEMENT DISORDER 31
654 ORTHOSTATIC HYPOTENSION 31
655 PERICARDIAL EFFUSION 31
656 PHARMACEUTICAL PRODUCT COMPLAINT 31
657 SKIN FISSURES 31
658 SNEEZING 31
659 SOCIAL PROBLEM 31
660 SPINAL OPERATION 31
661 TRANSAMINASES INCREASED 31
662 VENTRICULAR TACHYCARDIA 31
663 VITAMIN D DEFICIENCY 31
664 ACUTE HEPATIC FAILURE 30
665 AFFECT LABILITY 30
666 BODY TEMPERATURE INCREASED 30
667 BRAIN NEOPLASM 30
668 BUNDLE BRANCH BLOCK RIGHT 30
669 COAGULOPATHY 30
670 CONTRAINDICATED PRODUCT ADMINISTERED 30
671 DERMATITIS CONTACT 30
672 EXOSTOSIS 30
673 EXTRA DOSE ADMINISTERED 30
674 FAECES DISCOLOURED 30
675 HIP FRACTURE 30
676 HYPOPHAGIA 30
677 JOINT RANGE OF MOTION DECREASED 30
678 LOWER LIMB FRACTURE 30
679 OPTIC ISCHAEMIC NEUROPATHY 30
680 PERIPHERAL COLDNESS 30
681 PERIPHERAL VASCULAR DISORDER 30
682 POOR QUALITY DRUG ADMINISTERED 30
683 UNRESPONSIVE TO STIMULI 30
684 ABDOMINAL PAIN LOWER 29
685 ACUTE RESPIRATORY DISTRESS SYNDROME 29
686 BLOOD SODIUM DECREASED 29
687 DEPRESSED LEVEL OF CONSCIOUSNESS 29
688 ENDOMETRIAL CANCER 29
689 EYE DISORDER 29
690 GAIT INABILITY 29
691 MASS 29
692 MULTIPLE SCLEROSIS 29
693 OSTEONECROSIS OF JAW 29
694 PARAESTHESIA ORAL 29
695 PNEUMONIA ASPIRATION 29
696 POLYCYTHAEMIA VERA 29
697 RESPIRATORY DISTRESS 29
698 SEDATION 29
699 SKIN HAEMORRHAGE 29
700 TOOTH FRACTURE 29
701 TOXIC CARDIOMYOPATHY 29
702 BEDRIDDEN 28
703 BIPOLAR DISORDER 28
704 BLOOD GROWTH HORMONE INCREASED 28
705 BLOOD OESTROGEN DECREASED 28
706 CARDIAC FAILURE ACUTE 28
707 CONCUSSION 28
708 COORDINATION ABNORMAL 28
709 DRUG LEVEL INCREASED 28
710 ENDOMETRIAL ADENOCARCINOMA 28
711 FULL BLOOD COUNT DECREASED 28
712 GASTRIC DISORDER 28
713 HICCUPS 28
714 INTRACARDIAC THROMBUS 28
715 LOW DENSITY LIPOPROTEIN INCREASED 28
716 MIGRAINE WITH AURA 28
717 MULTIPLE INJURIES 28
718 PRIAPISM 28
719 PULMONARY CONGESTION 28
720 PULMONARY THROMBOSIS 28
721 RASH GENERALISED 28
722 RETCHING 28
723 SEROTONIN SYNDROME 28
724 SERUM FERRITIN INCREASED 28
725 SPINAL COMPRESSION FRACTURE 28
726 SPINAL FRACTURE 28
727 TOOTH DISORDER 28
728 ACCIDENTAL OVERDOSE 27
729 ANEURYSM 27
730 ARTHROPOD BITE 27
731 BLOOD THYROID STIMULATING HORMONE DECREASED 27
732 CARDIAC DEATH 27
733 DELIRIUM 27
734 GASTRIC ULCER 27
735 HAEMATEMESIS 27
736 LIBIDO INCREASED 27
737 LIVER FUNCTION TEST INCREASED 27
738 LUNG NEOPLASM MALIGNANT 27
739 MUSCLE STRAIN 27
740 NODULE 27
741 PELVIC PAIN 27
742 PERFORMANCE ENHANCING PRODUCT USE 27
743 PHOTOPHOBIA 27
744 PRODUCT RESIDUE PRESENT 27
745 ARTERIAL OCCLUSIVE DISEASE 26
746 BACTERIAL INFECTION 26
747 BODY TEMPERATURE DECREASED 26
748 BURSITIS 26
749 CEREBRAL VENOUS THROMBOSIS 26
750 CHOLECYSTITIS 26
751 DENTAL CARIES 26
752 DEVICE EXPULSION 26
753 DIVERTICULUM 26
754 DYSLIPIDAEMIA 26
755 EJECTION FRACTION DECREASED 26
756 EYE INFECTION 26
757 FOOT DEFORMITY 26
758 GASTROENTERITIS VIRAL 26
759 IMMUNE SYSTEM DISORDER 26
760 IMPAIRED DRIVING ABILITY 26
761 IMPAIRED QUALITY OF LIFE 26
762 INFUSION SITE PAIN 26
763 INJECTION SITE URTICARIA 26
764 MICTURITION URGENCY 26
765 MULTIPLE FRACTURES 26
766 MUSCULOSKELETAL DISORDER 26
767 ORAL CANDIDIASIS 26
768 OSTEOMYELITIS 26
769 PARKINSON^S DISEASE 26
770 PERIPHERAL ISCHAEMIA 26
771 PROSTATIC DISORDER 26
772 RESPIRATORY TRACT CONGESTION 26
773 SENSORY DISTURBANCE 26
774 SMALL INTESTINAL OBSTRUCTION 26
775 SNORING 26
776 TACHYPNOEA 26
777 THIRST 26
778 UPPER-AIRWAY COUGH SYNDROME 26
779 VENTRICULAR HYPERTROPHY 26
780 ACUTE MYELOID LEUKAEMIA 25
781 AMENORRHOEA 25
782 BLOOD GLUCOSE FLUCTUATION 25
783 BLOOD IRON DECREASED 25
784 BLOOD OESTROGEN INCREASED 25
785 BLOOD TEST ABNORMAL 25
786 BONE LOSS 25
787 BREAST HYPERPLASIA 25
788 BRUGADA SYNDROME 25
789 CORONARY ARTERY DISSECTION 25
790 DELUSION 25
791 DRUG LEVEL DECREASED 25
792 EAR PAIN 25
793 EMBOLISM VENOUS 25
794 FRUSTRATION TOLERANCE DECREASED 25
795 GALLBLADDER DISORDER 25
796 GENERALISED TONIC-CLONIC SEIZURE 25
797 GINGIVAL PAIN 25
798 HEMIPARESIS 25
799 HYPERCHOLESTEROLAEMIA 25
800 INCORRECT PRODUCT STORAGE 25
801 LOSS OF EMPLOYMENT 25
802 LOWER RESPIRATORY TRACT INFECTION 25
803 NASAL DISCOMFORT 25
804 NEPHROPATHY TOXIC 25
805 PLASMA CELL MYELOMA 25
806 PROCEDURAL COMPLICATION 25
807 RASH PAPULAR 25
808 SUDDEN CARDIAC DEATH 25
809 TESTICULAR PAIN 25
810 VENOUS THROMBOSIS 25
811 VIRILISM 25
812 WEIGHT FLUCTUATION 25
813 ACNE FULMINANS 24
814 ANGINA UNSTABLE 24
815 DRUG RESISTANCE 24
816 EAR DISCOMFORT 24
817 ENERGY INCREASED 24
818 FEEDING DISORDER 24
819 HIATUS HERNIA 24
820 HIGH DENSITY LIPOPROTEIN DECREASED 24
821 HYPERCOAGULATION 24
822 HYPOMAGNESAEMIA 24
823 INCREASED TENDENCY TO BRUISE 24
824 LIGAMENT SPRAIN 24
825 MUSCLE TIGHTNESS 24
826 NO THERAPEUTIC RESPONSE 24
827 OBSESSIVE-COMPULSIVE DISORDER 24
828 PERSONALITY CHANGE 24
829 PNEUMONITIS 24
830 POLYURIA 24
831 POST PROCEDURAL HAEMORRHAGE 24
832 PRODUCT PACKAGING ISSUE 24
833 PULMONARY INFARCTION 24
834 RENAL ARTERY THROMBOSIS 24
835 SOMNAMBULISM 24
836 SQUAMOUS CELL CARCINOMA 24
837 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 24
838 ABASIA 23
839 BLOOD CALCIUM DECREASED 23
840 CHOLESTASIS 23
841 CORONARY ARTERY THROMBOSIS 23
842 DERMATITIS ALLERGIC 23
843 DIABETES MELLITUS INADEQUATE CONTROL 23
844 INTERSTITIAL LUNG DISEASE 23
845 KIDNEY INFECTION 23
846 LEUKOPENIA 23
847 METAPLASIA 23
848 MYOCARDIAL FIBROSIS 23
849 MYOPATHY 23
850 NEOPLASM RECURRENCE 23
851 PNEUMONIA BACTERIAL 23
852 PRODUCT CONTAMINATION PHYSICAL 23
853 PRODUCT PREPARATION ERROR 23
854 PSYCHOMOTOR HYPERACTIVITY 23
855 SCOLIOSIS 23
856 SKIN REACTION 23
857 THERAPY PARTIAL RESPONDER 23
858 TOOTH ABSCESS 23
859 VITAMIN D DECREASED 23
860 WRIST FRACTURE 23
861 AORTIC STENOSIS 22
862 AORTIC VALVE INCOMPETENCE 22
863 APLASTIC ANAEMIA 22
864 AUTOIMMUNE THYROIDITIS 22
865 BLINDNESS TRANSIENT 22
866 BLINDNESS UNILATERAL 22
867 CARDIAC MURMUR 22
868 CONCOMITANT DISEASE AGGRAVATED 22
869 DEVICE MECHANICAL ISSUE 22
870 EYE MOVEMENT DISORDER 22
871 FAMILY STRESS 22
872 FOOD CRAVING 22
873 GROIN PAIN 22
874 HAEMORRHAGE INTRACRANIAL 22
875 HALLUCINATION, AUDITORY 22
876 HEART INJURY 22
877 HYPERBILIRUBINAEMIA 22
878 IMMUNE THROMBOCYTOPENIA 22
879 INCORRECT PRODUCT ADMINISTRATION DURATION 22
880 INITIAL INSOMNIA 22
881 LACUNAR INFARCTION 22
882 MAJOR DEPRESSION 22
883 MULTIPLE ALLERGIES 22
884 MUSCLE MASS 22
885 MYOSITIS 22
886 NEPHROGENIC ANAEMIA 22
887 PLANTAR FASCIITIS 22
888 POST-TRAUMATIC STRESS DISORDER 22
889 PRODUCT DISTRIBUTION ISSUE 22
890 RENAL CYST 22
891 SCIATICA 22
892 UPPER GASTROINTESTINAL HAEMORRHAGE 22
893 BREAST TENDERNESS 21
894 CAROTID ARTERY STENOSIS 21
895 CEREBROSPINAL FLUID LEAKAGE 21
896 CRANIOPHARYNGIOMA 21
897 DEMENTIA 21
898 DEVICE DIFFICULT TO USE 21
899 DEVICE USE ERROR 21
900 FEELING OF DESPAIR 21
901 GLOSSODYNIA 21
902 INTRAOCULAR PRESSURE INCREASED 21
903 LIP SWELLING 21
904 MALNUTRITION 21
905 MUSCLE RUPTURE 21
906 PARALYSIS 21
907 PERICARDITIS 21
908 PULMONARY FIBROSIS 21
909 STREPTOCOCCAL INFECTION 21
910 ABNORMAL WEIGHT GAIN 20
911 ADRENOCORTICAL INSUFFICIENCY ACUTE 20
912 ANKYLOSING SPONDYLITIS 20
913 BLADDER CANCER 20
914 BREAST CANCER METASTATIC 20
915 CERVIX CARCINOMA STAGE IV 20
916 CLOSTRIDIUM DIFFICILE COLITIS 20
917 CONJUNCTIVITIS 20
918 DECREASED IMMUNE RESPONSIVENESS 20
919 DEVICE USE ISSUE 20
920 DISSEMINATED INTRAVASCULAR COAGULATION 20
921 DRUG DISPENSING ERROR 20
922 DRUG PRESCRIBING ERROR 20
923 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20
924 HAEMOGLOBIN ABNORMAL 20
925 HAEMORRHAGIC STROKE 20
926 INJECTION SITE RASH 20
927 LARGE INTESTINE POLYP 20
928 LOCAL SWELLING 20
929 LYMPHOMA 20
930 MOUTH ULCERATION 20
931 MUSCLE FATIGUE 20
932 NERVE COMPRESSION 20
933 OESTRADIOL INCREASED 20
934 ORAL HERPES 20
935 PAIN OF SKIN 20
936 PRODUCT FORMULATION ISSUE 20
937 PRODUCT LABEL ISSUE 20
938 SINUS CONGESTION 20
939 SLUGGISHNESS 20
940 SYSTEMIC LUPUS ERYTHEMATOSUS 20
941 TASTE DISORDER 20
942 TENDERNESS 20
943 TOOTH EXTRACTION 20
944 TRICUSPID VALVE INCOMPETENCE 20
945 ULCER 20
946 VENTRICULAR EXTRASYSTOLES 20
947 APPLICATION SITE REACTION 19
948 APPLICATION SITE VESICLES 19
949 BLOOD POTASSIUM INCREASED 19
950 C-REACTIVE PROTEIN INCREASED 19
951 CHOLESTATIC LIVER INJURY 19
952 DECREASED INTEREST 19
953 DEVICE FAILURE 19
954 EUPHORIC MOOD 19
955 GASTROENTERITIS 19
956 GASTROINTESTINAL INFECTION 19
957 GASTROINTESTINAL PAIN 19
958 GLAUCOMA 19
959 HAIR COLOUR CHANGES 19
960 HAIR TEXTURE ABNORMAL 19
961 HORDEOLUM 19
962 HYPOKINESIA 19
963 ILEUS 19
964 IMPLANT SITE SWELLING 19
965 INFUSION SITE ERYTHEMA 19
966 INFUSION SITE SWELLING 19
967 LEFT VENTRICULAR FAILURE 19
968 MYOCLONUS 19
969 PERIORBITAL OEDEMA 19
970 PNEUMOTHORAX 19
971 PRODUCT SOLUBILITY ABNORMAL 19
972 SKIN MASS 19
973 SKIN PAPILLOMA 19
974 SQUAMOUS CELL CARCINOMA OF SKIN 19
975 SUPRAVENTRICULAR TACHYCARDIA 19
976 THERAPY CHANGE 19
977 WALKING AID USER 19
978 WOUND COMPLICATION 19
979 ALTERED STATE OF CONSCIOUSNESS 18
980 ANORGASMIA 18
981 BLADDER DISORDER 18
982 BONE DEMINERALISATION 18
983 CEREBRAL VENOUS SINUS THROMBOSIS 18
984 CORONARY ARTERY STENOSIS 18
985 DIZZINESS POSTURAL 18
986 ELECTROCARDIOGRAM ABNORMAL 18
987 ENLARGED CLITORIS 18
988 FEELING DRUNK 18
989 HEPATIC CIRRHOSIS 18
990 HUNGER 18
991 INFERTILITY MALE 18
992 INJECTION SITE NODULE 18
993 INTENTIONAL DRUG MISUSE 18
994 INTENTIONAL SELF-INJURY 18
995 IRON DEFICIENCY ANAEMIA 18
996 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 18
997 LUNG INFILTRATION 18
998 MENISCUS INJURY 18
999 OESOPHAGITIS 18